已收录 268921 条政策
 政策提纲
  • 暂无提纲
Study Identifies NSCLC Patients Who Are More Likely to Have Improved Progression-Free Survival on Third-Generation EGFR-TKI Therapy - Clinical Lab Products
[摘要] Theblood-basedproteomictesthelpsidentifynon-smallcelllungcancerpatientsforepidermalgrowthfactorreceptortyrosinekinaseinhibitortherapy.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学
[关键词]  [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文